Search

Your search keyword '"Carcinoma -- Forecasts and trends -- Reports -- Statistics"' showing total 3 results
Start Over Descriptor "Carcinoma -- Forecasts and trends -- Reports -- Statistics"
3 results on '"Carcinoma -- Forecasts and trends -- Reports -- Statistics"'

1. Urothelial Carcinoma Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight

Subjects
Merck & Company Inc. -- Product development -- Forecasts and trends, Pfizer Inc. -- Product development -- Forecasts and trends, Nektar Therapeutics -- Forecasts and trends -- Product development, AstraZeneca PLC -- Forecasts and trends -- Product development, Eli Lilly and Co. -- Product development -- Forecasts and trends, Business -- Research, BCG vaccines -- Product development -- Statistics, BCG -- Product development -- Statistics, Carcinoma -- Forecasts and trends -- Reports -- Statistics, Cancer -- Care and treatment -- Forecasts and trends -- Reports -- Statistics, Drug approval -- Statistics -- Reports -- Forecasts and trends, Epidemiology -- Forecasts and trends -- Reports -- Statistics, Market trend/market analysis, Business, Business, international, Opdivo (Medication) -- Product development -- Reports -- Statistics
Abstract

M2 PRESSWIRE-December 6, 2024-: Urothelial Carcinoma Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:06122024 Urothelial Carcinoma Companies [...]

Published
2024

2. Clear Cell Carcinoma Market to Show a Rise During the Forecast Period | F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc

Subjects
Pfizer Inc. -- Forecasts and trends, Mylan N.V. -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Business -- Research, Carcinoma -- Forecasts and trends -- Reports -- Statistics, Brand equity -- Forecasts and trends -- Statistics -- Reports, Epidemiology -- Forecasts and trends -- Reports -- Statistics, Cancer -- Forecasts and trends -- Reports -- Statistics, Pharmaceutical industry -- Statistics -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-May 15, 2024-: Clear Cell Carcinoma Market to Show a Rise During the Forecast Period | F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc. [...]

Published
2024

3. Clear Cell Carcinoma Market to Show a Rise During the Forecast Period, asserts DelveInsight

Subjects
Business -- Research, Carcinoma -- Forecasts and trends -- Reports -- Statistics, Brand equity -- Forecasts and trends -- Statistics -- Reports, Epidemiology -- Forecasts and trends -- Reports -- Statistics, Cancer -- Forecasts and trends -- Reports -- Statistics, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-December 9, 2022-: Clear Cell Carcinoma Market to Show a Rise During the Forecast Period, asserts DelveInsight (C)1994-2022 M2 COMMUNICATIONS RDATE:08122022 DelveInsight's 'Clear Cell Carcinoma Market Insights, Epidemiology, and [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results